Clinical Trial Update: BY002 IIT Study in R/R Acute Leukemia [Phase 1]

View source ↗

Summary

Investigator-initiated phase 1 trial of BY002 in relapsed/refractory acute leukemia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• BY002

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Leukemia, KMT2A Rearrangements or NPM1 Mutations Acute Leukemia | Phase 1 | Status: RECRUITING